Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medibank PvtASX:MPL +0.79%79 EV-to-EBIT is 19.81 as of Jul. 13, 2026, which is 34% above its 10-year median of 14.76. GuruFocus rates ASX:MPL with a GF Score™ of 79/100 and a GF Value™ of A$4.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 347 Insurance companies, Medibank Pvt ranks worse than 84.44% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Medibank Pvt's Enterprise Value for the quarter that ended in Dec. 2025 was A$13,014 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medibank Pvt's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$697 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt EV-to-EBIT Related Terms
Medibank Pvt EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Medibank Pvt's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Specialty subindustry, Medibank Pvt's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt EV-to-EBIT vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's EV-to-EBIT falls into.
Medibank Pvt's current Enterprise Value is A$13,813 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medibank Pvt's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$697 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (ASX:MPL) has a EV-to-EBIT of 19.81 as of Jul. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medibank Pvt and its competitors. This is 34% above median its historical median of 14.76. Over the past decade, Medibank Pvt's EV-to-EBIT has ranged from 12.08 to 19.65. According to the industry distribution chart, Medibank Pvt ranks #293 out of 347 companies in the Insurance industry, placing it in the top 84.4%.
Is Medibank Pvt's EV-to-EBIT too high?
Medibank Pvt's current EV-to-EBIT of 19.81 is 34% above median its 10-year median of 14.76. Over the past 10 years, this metric has ranged from a low of 12.08 to a high of 19.65. The Insurance industry median EV-to-EBIT is 8.73. Medibank Pvt's value of 19.81 is 126.9% above this industry median. Based on the distribution chart, Medibank Pvt ranks #293 out of 347 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Medibank Pvt has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's EV-to-EBIT compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #293 out of 347 companies for EV-to-EBIT. This places Medibank Pvt in the lower half of its industry. The industry median EV-to-EBIT is 8.73. Medibank Pvt's value of 19.81 is 126.9% above this benchmark. Historically, Medibank Pvt's own EV-to-EBIT has ranged from 12.08 to 19.65 over the past decade. While the company's 10-year median is 14.76 vs. the industry median of 8.73, Medibank Pvt has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Insurance company?
The median EV-to-EBIT among Insurance companies is 8.73, based on 347 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current EV-to-EBIT of 19.81 is 126.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medibank Pvt and its competitors. For the Insurance industry, the median EV-to-EBIT is 8.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current EV-to-EBIT is 19.81, which is 34% above median its own 10-year median of 14.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.40, compared to a current price of A$5.08 — trading 15.5% above its estimated fair value. The current EV-to-EBIT is 19.81, which is 34% above median its 10-year median of 14.76 and 126.9% above the Insurance industry median of 8.73. Medibank Pvt's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current EV-to-EBIT is 19.81 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.08 is trading 15.5% above its estimated GF Value™ of A$4.40.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
EV-to-EBIT: 19.81 (34% above median its 10-year median of 14.76)
GF Value™: A$4.40 vs. price of A$5.08 (15.5% above fair value)
Industry Position: 126.9% above the Insurance median (#293 of 347)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
79GF Score
Get the complete analysis for ASX:MPL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
